Coral Laboratories Ltd: Intrinsic Value & Share Price Analysis

Q: What is the current share price and 52-week range of Coral Laboratories Ltd?

Coral Laboratories Ltd is trading at 383.00 as of 20 April 2026, with a FY2026-2027 high of 785 and low of 360. The stock is currently near its 52-week low. Market cap stands at 137 Cr..

Q: Is Coral Laboratories Ltd financially healthy?

Key indicators: ROCE of 17.4 % indicates efficient capital utilization. Dividend yield is 0.39 %.

Q: Is Coral Laboratories Ltd profitable and how is the profit trend?

Coral Laboratories Ltd reported a net profit of 24 Cr in Mar 2025 on revenue of 115 Cr. Compared to 9 Cr in Mar 2022, the net profit shows an improving trend.

Fair Value

₹600.08Undervalued by 56.68%vs CMP ₹383.00

P/E (9.6) × ROE (13.1%) × BV (₹596.00) × DY (0.39%)

₹584.19Undervalued by 52.53%vs CMP ₹383.00

MoS: +34.4% (Strong)Confidence: 60/100 (Moderate)Models: 6 Under, 2 Fair, 1 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹654.71	23%	Under (+70.9%)
Graham Number	Earnings	₹724.66	16%	Under (+89.2%)
Earnings Power	Earnings	₹362.19	11%	Fair (-5.4%)
DCF	Cash Flow	₹624.57	14%	Under (+63.1%)
Net Asset Value	Assets	₹598.26	7%	Under (+56.2%)
EV/EBITDA	Enterprise	₹623.42	9%	Under (+62.8%)
Earnings Yield	Earnings	₹391.60	7%	Fair (+2.2%)
ROCE Capital	Returns	₹631.61	7%	Under (+64.9%)
Revenue Multiple	Revenue	₹321.50	5%	Over (-16.1%)
Consensus (9 models)		₹584.19	100%	Undervalued

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 9.1%

*Investments are subject to market risks

Analyst Summary

Coral Laboratories Ltd operates in the Pharmaceuticals segment, NSE: CORALAB | BSE: 524506, current market price is ₹383.00, market cap is 137 Cr.. At a glance, stock P/E is 9.57, ROE is 13.1 %, ROCE is 17.4 %, book value is 596, dividend yield is 0.39 %. The latest intrinsic value estimate is ₹584.19, which is about 52.5% above the current price, so the page currently reads as potentially undervalued rather than fully priced. On operating trend, latest reported sales are about ₹115 Cr versus the prior period change of 36.9%, while latest net profit is about ₹24 Cr with a prior-period change of 50.0%. This analysis page also carries profit and loss, shareholding pattern, ratio panels data, which improves the depth of the template beyond a thin price-only snapshot. The 52-week range shown on this page is 785/360, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisCoral Laboratories Ltd. is a Public Limited Listed company incorporated on 06/02/1997 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24231MH1997PLC422233 and registration number is 422233. Currently Company is…

This summary is generated from the stock page data available for Coral Laboratories Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

Coral Laboratories Ltd scores 55/100 (Average)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health77/100 · Strong

ROCE 17.4% GoodROE 13.1% GoodD/E 0.04 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent

Smart Money50/100 · Moderate

FII holding stable No changePromoter holding at 71.5% Stable

Earnings Quality55/100 · Moderate

OPM expanding (8% → 21%) ImprovingWorking capital: 140 days Capital intensive

Quarterly Momentum15/100 · Weak

Revenue (4Q): -24% YoY DecliningProfit (4Q): -48% YoY DecliningOPM: 8.8% (down 18.7% YoY) Margin pressure

Industry Rank65/100 · Strong

P/E 9.6 vs industry 53.8 Cheaper than peersROCE 17.4% vs industry 16.4% Average3Y sales CAGR: 15% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:24 am

Market Cap	137 Cr.
Current Price	383
Intrinsic Value	₹584.19
High / Low	785/360
Stock P/E	9.57
Book Value	596
Dividend Yield	0.39 %
ROCE	17.4 %
ROE	13.1 %
Face Value	10.0
PEG Ratio	1.05

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Coral Laboratories Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Coral Laboratories Ltd	137 Cr.	383	785/360	9.57	596	0.39 %	17.4 %	13.1 %	10.0
Achyut Healthcare Ltd	132 Cr.	5.62	6.80/3.00	308	1.34	0.00 %	2.26 %	1.77 %	1.00
Brooks Laboratories Ltd	131 Cr.	44.5	166/36.3	6.07	39.3	0.00 %	9.93 %	12.2 %	10.0
Aarey Drugs & Pharmaceuticals Ltd	151 Cr.	53.3	100/41.1	44.0	52.5	0.00 %	6.38 %	2.96 %	10.0
Gujarat Inject (Kerala) Ltd	120 Cr.	82.1	82.1/17.0	481	6.93	0.00 %	13.5 %	11.0 %	10.0
Industry Average	19,815.15 Cr	1,053.84		53.84	201.20	0.39%	16.35%	15.16%	6.10

All Competitor Stocks of Coral Laboratories Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	24.73	11.44	13.55	23.15	18.08	28.89	31.66	32.23	22.99	28.13	18.82	19.03	21.56
Expenses	23.88	13.52	11.81	17.00	15.98	22.64	20.92	25.72	16.67	25.44	16.64	14.09	19.67
Operating Profit	0.85	-2.08	1.74	6.15	2.10	6.25	10.74	6.51	6.32	2.69	2.18	4.94	1.89
OPM %	3.44%	-18.18%	12.84%	26.57%	11.62%	21.63%	33.92%	20.20%	27.49%	9.56%	11.58%	25.96%	8.77%
Other Income	1.54	1.16	1.29	1.81	1.37	2.00	1.56	2.54	2.52	1.71	2.05	3.03	2.49
Interest	0.11	0.02	0.00	0.00	0.00	0.00	0.03	0.01	0.02	0.04	0.06	0.10	0.00
Depreciation	0.50	0.68	0.55	0.44	0.49	0.50	0.49	0.51	0.50	0.51	0.45	0.45	0.69
Profit before tax	1.78	-1.62	2.48	7.52	2.98	7.75	11.78	8.53	8.32	3.85	3.72	7.42	3.69
Tax %	51.69%	-45.06%	26.21%	20.21%	27.52%	25.16%	25.21%	25.21%	26.08%	26.49%	31.18%	21.56%	24.93%
Net Profit	0.86	-0.89	1.84	6.00	2.16	5.79	8.80	6.38	6.14	2.83	2.56	5.82	2.78
EPS in Rs	2.41	-2.49	5.15	16.79	6.05	16.21	24.63	17.86	17.19	7.92	7.17	16.29	7.78

Last Updated: March 3, 2026, 11:12 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 2:50 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	51	59	77	95	92	91	71	97	76	78	84	115	88
Expenses	41	47	60	72	77	79	65	81	67	74	67	89	76
Operating Profit	10	12	16	23	15	12	5	16	8	4	16	26	12
OPM %	20%	21%	21%	24%	17%	14%	8%	16%	11%	5%	19%	23%	13%
Other Income	1	3	3	3	4	5	6	4	6	7	6	8	9
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	1	3	2	2	2	2	2	2	2	2	2	2	2
Profit before tax	10	12	17	25	18	16	9	18	12	8	21	32	19
Tax %	21%	22%	29%	34%	31%	34%	22%	23%	24%	22%	24%	26%
Net Profit	8	10	12	16	12	10	7	14	9	6	16	24	14
EPS in Rs	22.03	26.79	34.71	45.63	34.85	28.61	19.96	37.93	25.33	18.05	44.20	67.63	39.16
Dividend Payout %	9%	9%	9%	11%	6%	7%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	25.00%	20.00%	33.33%	-25.00%	-16.67%	-30.00%	100.00%	-35.71%	-33.33%	166.67%	50.00%
Change in YoY Net Profit Growth (%)	0.00%	-5.00%	13.33%	-58.33%	8.33%	-13.33%	130.00%	-135.71%	2.38%	200.00%	-116.67%

Coral Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	7%
5 Years:	10%
3 Years:	15%
TTM:	0%

Compounded Profit Growth
10 Years:	10%
5 Years:	28%
3 Years:	44%
TTM:	-19%

Stock Price CAGR
10 Years:	1%
5 Years:	9%
3 Years:	21%
1 Year:	-48%

Return on Equity
10 Years:	10%
5 Years:	9%
3 Years:	9%
Last Year:	13%

Last Updated: September 5, 2025, 3:01 pm

Balance Sheet

Last Updated: February 1, 2026, 2:36 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	4	4	4	4	4	4	4	4	4	4	4	4	4
Reserves	47	56	67	106	113	110	112	133	152	151	174	198	210
Borrowings	0	1	0	2	2	1	6	6	6	0	0	4	1
Other Liabilities	10	12	19	20	22	21	23	25	28	20	28	25	19
Total Liabilities	60	72	89	131	140	136	144	168	190	174	206	229	233
Fixed Assets	20	19	18	18	22	23	23	21	24	25	24	23	24
CWIP	0	0	0	0	0	0	0	0	2	0	0	2	14
Investments	1	1	5	39	45	28	25	33	46	41	50	52	57
Other Assets	40	52	67	74	73	84	97	112	118	108	132	152	138
Total Assets	60	72	89	131	140	136	144	168	190	174	206	229	233

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	1	0	5	11	13	-1	-4	1	6	13	-5	-1
Cash from Investing Activity +	1	-0	-3	-10	-13	3	-2	-0	-6	-3	1	-0
Cash from Financing Activity +	0	-0	-0	0	-3	-1	4	0	0	-6	0	3
Net Cash Flow	2	-0	2	1	-2	1	-2	1	0	4	-4	1
Free Cash Flow	1	-1	4	9	9	-4	-5	-0	1	11	-6	-4
CFO/OP	29%	30%	70%	85%	124%	31%	-59%	28%	127%	383%	-4%	23%

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	10.00	11.00	16.00	21.00	13.00	11.00	-1.00	10.00	2.00	4.00	16.00	22.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	109	152	132	117	125	122	178	148	184	109	123	107
Inventory Days	97	110	110	155	120	116	176	158	169	100	149	68
Days Payable	61	66	80	75	87	91	129	108	81	34	130	46
Cash Conversion Cycle	145	196	162	197	157	146	225	198	272	176	142	129
Working Capital Days	158	194	179	164	161	171	241	178	222	221	183	140
ROCE %	21%	22%	27%	28%	16%	13%	8%	13%	7%	5%	13%	17%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%
FIIs	0.14%	0.14%	0.14%	0.14%	0.14%	0.23%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	28.34%	28.35%	28.34%	28.35%	28.35%	28.26%	28.50%	28.49%	28.49%	28.50%	28.49%	28.48%
No. of Shareholders	4,046	4,040	3,981	4,005	4,098	3,831	3,949	4,054	4,105	4,213	4,286	4,208

Shareholding Pattern Chart

No. of Shareholders

Coral Laboratories Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	67.61	44.19	18.04	25.32	37.94
Diluted EPS (Rs.)	67.61	44.19	18.04	25.32	37.94
Cash EPS (Rs.)	73.24	49.72	24.14	30.89	43.49
Book Value[Excl.RevalReserv]/Share (Rs.)	563.19	496.83	433.29	436.81	382.48
Book Value[Incl.RevalReserv]/Share (Rs.)	563.19	496.83	433.29	436.81	382.48
Dividend / Share (Rs.)	1.50	2.00	0.00	0.00	0.00
Revenue From Operations / Share (Rs.)	321.91	234.17	218.66	211.64	270.30
PBDIT / Share (Rs.)	98.94	64.02	29.97	36.47	54.91
PBIT / Share (Rs.)	93.31	58.49	23.87	30.89	49.37
PBT / Share (Rs.)	90.89	58.03	23.02	33.19	49.25
Net Profit / Share (Rs.)	67.61	44.19	18.04	25.32	37.94
PBDIT Margin (%)	30.73	27.33	13.70	17.23	20.31
PBIT Margin (%)	28.98	24.97	10.91	14.59	18.26
PBT Margin (%)	28.23	24.78	10.53	15.67	18.21
Net Profit Margin (%)	21.00	18.87	8.25	11.96	14.03
Return on Networth / Equity (%)	12.00	8.89	4.16	5.79	9.91
Return on Capital Employeed (%)	16.30	11.55	5.24	6.71	12.61
Return On Assets (%)	10.52	7.67	3.69	4.76	8.09
Total Debt / Equity (X)	0.01	0.00	0.00	0.03	0.04
Asset Turnover Ratio (%)	0.52	0.44	0.42	0.42	0.61
Current Ratio (X)	7.07	6.18	10.42	5.13	3.99
Quick Ratio (X)	6.68	5.57	9.36	4.41	3.21
Inventory Turnover Ratio (X)	9.19	2.87	2.68	1.92	2.39
Dividend Payout Ratio (NP) (%)	2.95	0.00	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	2.73	0.00	0.00	0.00	0.00
Earning Retention Ratio (%)	97.05	0.00	0.00	0.00	0.00
Cash Earning Retention Ratio (%)	97.27	0.00	0.00	0.00	0.00
Interest Coverage Ratio (X)	362.17	114356.50	31.63	92.33	461.63
Interest Coverage Ratio (Post Tax) (X)	256.38	79763.50	19.93	58.31	319.93
Enterprise Value (Cr.)	174.27	71.40	41.37	59.77	86.55
EV / Net Operating Revenue (X)	1.52	0.85	0.52	0.79	0.89
EV / EBITDA (X)	4.93	3.12	3.86	4.59	4.41
MarketCap / Net Operating Revenue (X)	2.18	1.59	1.05	1.21	1.19
Retention Ratios (%)	97.04	0.00	0.00	0.00	0.00
Price / BV (X)	1.25	0.74	0.52	0.58	0.84
Price / Net Operating Revenue (X)	2.18	1.59	1.05	1.21	1.19
EarningsYield	0.09	0.11	0.07	0.09	0.11

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Coral Laboratories Ltd. is a Public Limited Listed company incorporated on 06/02/1997 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24231MH1997PLC422233 and registration number is 422233. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 115.01 Cr. and Equity Capital is Rs. 3.57 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	3B, Patanwala Compound, Mumbai Maharashtra 400086	Contact not found

Management
Name	Position Held
Mr. Rajendrasinh Rana	Director
Mr. Girish M Dhameja	Whole Time Director
Mrs. Sushma Kadkade	Director & CFO
Ms. Pooja Hindia	Independent Director
Dr. Saurabh Shah	Independent Director
Mr. Malay Doshi	Independent Director

FAQ

What is the intrinsic value of Coral Laboratories Ltd and is it undervalued?

As of 20 April 2026, Coral Laboratories Ltd's intrinsic value is ₹584.19, which is 52.53% higher than the current market price of ₹383.00, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (13.1 %), book value (₹596), dividend yield (0.39 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Coral Laboratories Ltd?

Coral Laboratories Ltd is trading at ₹383.00 as of 20 April 2026, with a FY2026-2027 high of ₹785 and low of ₹360. The stock is currently near its 52-week low. Market cap stands at ₹137 Cr..

How does Coral Laboratories Ltd's P/E ratio compare to its industry?

Coral Laboratories Ltd has a P/E ratio of 9.57, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Coral Laboratories Ltd financially healthy?

Key indicators for Coral Laboratories Ltd: ROCE of 17.4 % indicates efficient capital utilization. Dividend yield is 0.39 %.

Is Coral Laboratories Ltd profitable and how is the profit trend?

Coral Laboratories Ltd reported a net profit of ₹24 Cr in Mar 2025 on revenue of ₹115 Cr. Compared to ₹9 Cr in Mar 2022, the net profit shows an improving trend.

Does Coral Laboratories Ltd pay dividends?

Coral Laboratories Ltd has a dividend yield of 0.39 % at the current price of ₹383.00. The company pays dividends, though the yield is modest.